Why Barrière Thinks You'll Want To Wear You Vitamins

TL;DR

Barrière sells transdermal vitamin patches targeting young wellness consumers, but clinical evidence for skin-absorbed supplements remains largely unproven.

Key Points

• 1.Barrière is scaling rapidly in retail. After a successful 50-store Walmart test, the company is now in 1,700 Walmart locations and over 6,000 stores total, projecting 2026 revenue of $10 million — more than double 2025 — with a $19 million valuation.
• 2.The patch format targets behavioral habits, not just biology. CEO says the real problem is making a product people want to use daily; stylish, trend-driven patches modeled on pimple-patch culture (e.g., Scarface) appeal to younger consumers who prefer convenience over pills.
• 3.Barrière claims a world first with a lactose relief patch. Its product lineup ranges from $13–$18 per patch and includes nausea support (ginger, peppermint, B6) and the first-ever transdermal lactose intolerance patch, differentiating it from rivals like The Good Patch.
• 4.Clinical evidence for transdermal supplements is weak, and regulation is minimal. The Dietary Supplement Health and Education Act of 1994 classifies supplements as food, not drugs; Barrière's own trial had only 30 subjects and no control group, and the company says clinical trials remain a 3–5 year goal.